logoTry Persana

Arpeggio Biosciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Arpeggio Biosciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Arpeggio Biosciences company logo

Innovative platform for drug development and cellular dynamics.

Arpeggio Biosciences leverages machine learning algorithms and proprietary biological assays to analyze cellular dynamics for drug development.

HeadquartersBoulder, Colorado, United States
Team size11-50
Founded2017

What is Arpeggio Biosciences? - Company Overview & Details

Arpeggio Biosciences is Arpeggio Biosciences leverages machine learning algorithms and proprietary biological assays to analyze cellular dynamics for drug development. Founded in 2017, the company is headquartered in Boulder, Colorado, United States.

Who Founded Arpeggio Biosciences?

Arpeggio Biosciences was founded by Joey Azofeifa.

Who are the Key Executives at Arpeggio Biosciences? - Leadership Team

Arpeggio Biosciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Arpeggio Biosciences

Joey AzofeifaCEO

Chief Technology Officer (CTO) of Arpeggio Biosciences

CTO

About Joey Azofeifa - CEO of Arpeggio Biosciences

Joey Azofeifa serves as the Chief Executive Officer of Arpeggio Biosciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Arpeggio Biosciences Company Details & Key Information

Where is Arpeggio Biosciences located?

Arpeggio Biosciences is headquartered in Boulder, Colorado, United States.

How many employees does Arpeggio Biosciences have?

Arpeggio Biosciences has 11-50 employees.

When was Arpeggio Biosciences founded?

Arpeggio Biosciences was founded in 2017.

Arpeggio Biosciences Official Website

How much funding has Arpeggio Biosciences raised?

Arpeggio Biosciences has raised $20.2 Million across 4 funding rounds. The most recent funding was completed on 2022-10-07.

Funding Overview

Arpeggio Biosciences has raised a total of $20.2 million across its funding rounds to advance its drug development technologies.

$20.2 Million
Total Funding Raised
4
Funding Rounds
2022-10-07
Latest Round

Arpeggio Biosciences Funding History

Series A
2022-10-07
$17 Million
Seed
2020-01-15
$3.2 Million

Who are the key investors in Arpeggio Biosciences?

Arpeggio Biosciences is backed by 5 key investors including Builders VC, Khosla Ventures, TechU Ventures. These investors focus on Healthcare, Biotechnology, Life Sciences sectors.

Arpeggio Biosciences Investor Overview

5
Key Investors
3
Focus Areas
2
Notable Investments

Complete List of Arpeggio Biosciences Investors

Builders VC

An early-stage venture capital firm focused on investing in technology-driven companies.

Investment Focus
Healthcare
Biotechnology
Notable Portfolio Companies
N/A

Khosla Ventures

A venture capital firm that invests in technology-oriented companies.

Investment Focus
Life Sciences
Healthcare
Notable Portfolio Companies
N/A

TechU Ventures

FundersClub

Fifty Years

What sectors do Arpeggio Biosciences investors focus on?

The investors backing Arpeggio Biosciences primarily focus on Healthcare, Biotechnology, Life Sciences sectors.

Healthcare
Biotechnology
Life Sciences

Featured Investor: Builders VC

Builders VC

An early-stage venture capital firm focused on investing in technology-driven companies.

Notable Investments: N/A

What are Arpeggio Biosciences's future plans?

Arpeggio Biosciences Focus on advancing drug discovery technologies and expanding partnerships.

Arpeggio Biosciences Strategic Outlook

Strategic Focus
Defined
1
Key Challenges
2
Growth Opportunities

What challenges does Arpeggio Biosciences face?

Arpeggio Biosciences has identified 1 key challenges that need to be addressed for continued growth and success.

Key Challenges for Arpeggio Biosciences

1

Competing with established pharmaceutical companies

What opportunities does Arpeggio Biosciences have?

Arpeggio Biosciences has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Arpeggio Biosciences

1

Expanding into new therapeutic areas

2

Potential partnerships with biotech firms

Arpeggio Biosciences Strategic Position Summary

Key Focus Areas

Arpeggio Biosciences is addressing 1 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Arpeggio Biosciences?

Arpeggio Biosciences has 2 recent news updates covering key business developments and market activities.

Arpeggio Biosciences News Overview

2
Recent Articles
Active
Media Coverage
2022-09-06
Latest Update

What is Arpeggio Biosciences in the news for?

Arpeggio Biosciences is currently featured in news for Arpeggio Biosciences received financing of $17M in Series A on Sep 7th '22. and other significant business developments.

Recent News Articles About Arpeggio Biosciences

Article 1
2022-09-06

Arpeggio Biosciences received financing of $17M in Series A on Sep 7th '22.

Arpeggio Biosciences announced a $17 million Series A funding round led by Builders VC.

businesswire.com
Read News
Article 2
2020-01-14

Arpeggio Biosciences received financing of $3.2M in Seed on Jan 15th '20.

Arpeggio Bio raised $3.2 million in seed funding and CEO named to the 2020 Forbes 30 Under 30 List in Healthcare.

businesswire.com
Read News

Arpeggio Biosciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Arpeggio Biosciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Arpeggio Biosciences Questions & Answers - Company Information

Q1

What is Arpeggio Biosciences?

Arpeggio Biosciences leverages machine learning algorithms and proprietary biological assays to analyze cellular dynamics for drug development.

Q2

Who founded Arpeggio Biosciences?

Arpeggio Biosciences was founded by Joey Azofeifa.

Q3

Who is the CEO of Arpeggio Biosciences?

The CEO of Arpeggio Biosciences is Joey Azofeifa. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Arpeggio Biosciences raised?

Arpeggio Biosciences has raised a total of $$20.2 Million across 4 funding rounds. The most recent funding was completed on 2022-10-07.

Q5

Who are the investors in Arpeggio Biosciences?

Arpeggio Biosciences's key investors include Builders VC, Khosla Ventures, TechU Ventures, FundersClub, Fifty Years.

Q6

Where is Arpeggio Biosciences headquartered?

Arpeggio Biosciences is headquartered in Boulder, Colorado, United States.

Q7

When was Arpeggio Biosciences founded?

Arpeggio Biosciences was founded in 2017.

Q8

How many employees does Arpeggio Biosciences have?

Arpeggio Biosciences has 11-50 employees.

Q9

What is Arpeggio Biosciences's official website?

You can visit Arpeggio Biosciences's official website at http://www.arpeggiobio.com.

Q10

What was Arpeggio Biosciences's latest funding round?

Arpeggio Biosciences's latest funding round was a Series A round of $$17 Million completed on 2022-10-07.

Q11

Who is founder?

Joey Azofeifa

Q12

What does the company do?

Arpeggio Biosciences uses AI and biological assays for drug development and cellular dynamics analysis.

Q13

How much funding?

$20.2 Million

Q14

Latest funding date?

2022-10-07

Q15

Who are the investors?

Builders VC Khosla Ventures TechU Ventures FundersClub Fifty Years

Q16

What are the challenges?

Competing with established pharmaceutical companies

Q17

What are the opportunities?

Expanding into new therapeutic areas Potential partnerships with biotech firms

Q18

Latest news?

Arpeggio Biosciences announced a $17 million Series A funding round led by Builders VC. Arpeggio Bio raised $3.2 million in seed funding and CEO named to the 2020 Forbes 30 Under 30 List in Healthcare.

More Information About Arpeggio Biosciences

For additional details about Arpeggio Biosciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.